| |
|
| |
| The topic recently came up in an online think tank as to if Human are truly unique to all other anim ... - Lance Winslow |
| |
| When Marlo Thomas was an 18-year-old up-and-coming actress, she was devastated when journalists bega ... - Paul Stevens |
| |
|
|
| Lawrence Livermore National Laboratory (LLNL) Human Genome Center and Onyx Pharmaceuticals, Inc., re ... - Aaron Hall |
| |
|
Rab Fulton spins a unique and interesting tale in his novella, Transformation. Beginning as a romanc ... - write 2 right |
| |
|
"Debra Warren has appropriately titled her book of poetry ?Pausing to Catch My Breath?. The pages de ... - Lillian Brummet |
| |
|
Hair Today, Gone Tomorrow by Lisa Dunn-Dern is perfect for children aged four to eight. Large pages, ... - write 2 right |
| |
|
| |
|
|
| Author: Aaron Hall |
Lawrence Livermore National Laboratory (LLNL) Human Genome Center and Onyx Pharmaceuticals, Inc., recently signed an agreement to collaborate in developing automated, high-throughput methods for generating proteins from gene sequences. To help identify and characterize new therapeutic targets for Onyx's current drug-screening programs, research will focus on genes known to play a causative role in cancers. Joanna Albala of LLNL and Robin Clark and Anthony Davies of Onyx are principal investigators in the collaboration.
LLNL brings to the collaboration the Integrated Molecular Analysis of Gene Expression (called I.M.A.G.E.) collection of arrayed cDNA libraries, along with the expertise and infrastructure for miniaturizing and automating biological sample handling. Onyx has developed expertise and reagents for expressing proteins using the baculovirus expression system and for purifying a wide variety of human proteins using epitope tags. Investigators expect the new system to reduce drug-development time by providing a ready source of proteins for assay development and drug screening.
The 2-year collaboration is the first at LLNL to be funded under the Biotechnology Strategic Targets for Alliances in Research (BioSTAR) project. BioSTAR provides for university matching of private-sector funding for biotechnology research. |
Author Bio:
|
| You can also reach this article by using: LLNL and Onyx Collaborate on Proteome Project, Education & Reference, Science Programs |
|
|
|
|
